OS Cancer Research Results

OS, overall survival: Click to Expand ⟱
Source:
Type:
Overall survival

HNSCC, Head and Neck Squamous Cell Carcinoma: Click to Expand ⟱
Head and Neck Squamous Cell Carcinoma

Scientific Papers found: Click to Expand⟱
305- AgNPs,    Activity and pharmacology of homemade silver nanoparticles in refractory metastatic head and neck squamous cell cancer
- Case Report, HNSCC, NA
OS↑, Dose↓, BioAv↝, toxicity↓, Remission↑, other↝, other↝, other↝, Dose↝, BioAv↝,
5972- CET,  Rad,    Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Cancer
- Trial, HNSCC, NA
OS↑,
5970- CET,    Cetuximab
- Review, CRC, NA - Review, HNSCC, NA
EGFR↓, OS↑, QoL↑, Dose↝,
6682- DCA,  QC,    Dichloroacetate and Quercetin Prevent Cell Proliferation, Induce Cell Death and Slow Tumor Growth in a Mouse Model of HPV-Positive Head and Neck Cancer
- in-vivo, HNSCC, MEER
PDK1↓, lactateProd↓, GlucoseCon↓, tumCV↓, mTOR↓, Apoptosis↑, ROS↑, TumCG↓, pH↑, cl‑PARP↑, Casp3↑, DNAdam↑, p‑γH2AX↑, eff↓, OS↑,
5969- Rad,  CET,    Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
- Trial, HNSCC, NA
Dose↝, radioP↑, OS↑,
5971- Rad,  CET,    Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
- Trial, HNSCC, NA
OS↑,

Showing Research Papers: 1 to 6 of 6

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1)

ROS↑, 1,  

Core Metabolism/Glycolysis(tgid=4)

GlucoseCon↓, 1,   lactateProd↓, 1,   PDK1↓, 1,  

Cell Death(tgid=5)

Apoptosis↑, 1,   Casp3↑, 1,  

Transcription & Epigenetics(tgid=7)

other↝, 3,   tumCV↓, 1,  

DNA Damage & Repair(tgid=10)

DNAdam↑, 1,   cl‑PARP↑, 1,   p‑γH2AX↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

mTOR↓, 1,   TumCG↓, 1,  

Angiogenesis & Vasculature(tgid=14)

EGFR↓, 1,  

Cellular Microenvironment(tgid=17)

pH↑, 1,  

Drug Metabolism & Resistance(tgid=21)

BioAv↝, 2,   Dose↓, 1,   Dose↝, 3,   eff↓, 1,  

Clinical Biomarkers(tgid=22)

EGFR↓, 1,  

Functional Outcomes(tgid=23)

OS↑, 6,   QoL↑, 1,   radioP↑, 1,   Remission↑, 1,   toxicity↓, 1,  
Total Targets: 25

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: OS, overall survival
4 cetuximab
3 Radiotherapy/Radiation
1 Silver-NanoParticles
1 Dichloroacetate
1 Quercetin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:13  Cells:%  prod#:%  Target#:229  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page